274 related articles for article (PubMed ID: 34175492)
1. RASopathies: From germline mutations to somatic and multigenic diseases.
Riller Q; Rieux-Laucat F
Biomed J; 2021 Aug; 44(4):422-432. PubMed ID: 34175492
[TBL] [Abstract][Full Text] [Related]
2. Mosaic RASopathies.
Hafner C; Groesser L
Cell Cycle; 2013 Jan; 12(1):43-50. PubMed ID: 23255105
[TBL] [Abstract][Full Text] [Related]
3. Divergent effects of intrinsically active MEK variants on developmental Ras signaling.
Goyal Y; Jindal GA; Pelliccia JL; Yamaya K; Yeung E; Futran AS; Burdine RD; Schüpbach T; Shvartsman SY
Nat Genet; 2017 Mar; 49(3):465-469. PubMed ID: 28166211
[TBL] [Abstract][Full Text] [Related]
4. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
Schubbert S; Bollag G; Shannon K
Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
[TBL] [Abstract][Full Text] [Related]
5. RAS diseases in children.
Niemeyer CM
Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
[TBL] [Abstract][Full Text] [Related]
6. Molecular Genetics of Noonan Syndrome and RASopathies.
Liao J; Mehta L
Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Ras Pathway Signaling in Pediatric Cancer.
Ney GM; McKay L; Koschmann C; Mody R; Li Q
Cancer Res; 2020 Dec; 80(23):5155-5163. PubMed ID: 32907837
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in RASopathies.
Aoki Y; Niihori T; Inoue S; Matsubara Y
J Hum Genet; 2016 Jan; 61(1):33-9. PubMed ID: 26446362
[TBL] [Abstract][Full Text] [Related]
9. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
[TBL] [Abstract][Full Text] [Related]
10. The impact of RASopathy-associated mutations on CNS development in mice and humans.
Kang M; Lee YS
Mol Brain; 2019 Nov; 12(1):96. PubMed ID: 31752929
[TBL] [Abstract][Full Text] [Related]
11. RASopathy Gene Mutations in Melanoma.
Halaban R; Krauthammer M
J Invest Dermatol; 2016 Sep; 136(9):1755-1759. PubMed ID: 27236105
[TBL] [Abstract][Full Text] [Related]
12. [Rasopathies: developmental disorders that predispose to cancer and skin manifestations].
Hernández-Martín A; Torrelo A
Actas Dermosifiliogr; 2011; 102(6):402-16. PubMed ID: 21536246
[TBL] [Abstract][Full Text] [Related]
13. RAS signalling in energy metabolism and rare human diseases.
Dard L; Bellance N; Lacombe D; Rossignol R
Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):845-867. PubMed ID: 29750912
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
[TBL] [Abstract][Full Text] [Related]
15. Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.
Sala V; Gallo S; Leo C; Gatti S; Gelb BD; Crepaldi T
Mol Med; 2012 Sep; 18(1):938-47. PubMed ID: 22576369
[TBL] [Abstract][Full Text] [Related]
16. [RASopathies and hematologic abnormalities].
Aoki Y
Rinsho Ketsueki; 2015 Oct; 56(10):2240-7. PubMed ID: 26458465
[TBL] [Abstract][Full Text] [Related]
17. The sixth international RASopathies symposium: Precision medicine-From promise to practice.
Gripp KW; Schill L; Schoyer L; Stronach B; Bennett AM; Blaser S; Brown A; Burdine R; Burkitt-Wright E; Castel P; Darilek S; Dias A; Dyer T; Ellis M; Erickson G; Gelb BD; Green T; Gross A; Ho A; Holder JL; Inoue SI; Jelin AC; Kennedy A; Klein R; Kontaridis MI; Magoulas P; McConnell DB; McCormick F; Neel BG; Prada CE; Rauen KA; Roberts A; Rodriguez-Viciana P; Rosen N; Rumbaugh G; Sablina A; Solman M; Tartaglia M; Thomas A; Timmer WC; Venkatachalam K; Walsh KS; Wolters PL; Yi JS; Zenker M; Ratner N
Am J Med Genet A; 2020 Mar; 182(3):597-606. PubMed ID: 31825160
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies.
Catts DS; Mroske C; Clark RO; Hipp SJ; Berg JM; Hunter JM; Whiteway SL
J Pediatr Hematol Oncol; 2021 May; 43(4):e517-e520. PubMed ID: 32815881
[TBL] [Abstract][Full Text] [Related]
19. Understanding and drugging RAS: 40 years to break the tip of the iceberg.
Brady DC; Hmeljak J; Dar AC
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35244677
[TBL] [Abstract][Full Text] [Related]
20. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.
Tajan M; Paccoud R; Branka S; Edouard T; Yart A
Endocr Rev; 2018 Oct; 39(5):676-700. PubMed ID: 29924299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
